Sandra Mazzoli

Prof. Dr. Sandra Mazzoli


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
Francesco BrandaFrancesco Branda
Francesco Branda
MPMassimo Pierini
Massimo Pierini
SMSandra Mazzoli
Sandra Mazzoli

10 February 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
Francesco BrandaFrancesco Branda
Francesco Branda
AMAhmed Mahal
Ahmed Mahal
AMAntonello Maruotti
Antonello Maruotti
MPMassimo Pierini
Massimo Pierini
SMSandra Mazzoli
Sandra Mazzoli
On 20 September 2022, the Ministry of Health in Uganda, together with the World Health Organization—Regional Office for Africa (WHO AFRO) confirmed an outbreak of EVD due to Sudan ebolavirus in Mubende District, after one fatal case was confirmed. Real-time information are needed to provide crucial information to understand transmissibility, risk of geographical spread, routes of transmission, risk factors of infection, and provide the basis for epidemiological modelling that can inform response and containment planning to reduce the burden of disease. We made an effort to build a centralized repository of the Ebola virus cases from verified sources, providing information on dates of symptom onset, locations (aggregated to the district level), and when available, the gender and status of hospitals, reporting bed capacity and isolation unit occupancy rate according to the severity status of the patient. The proposed data repository provides researchers and policymakers timely, complete, and easy-accessible data to monitor the most recent trends of the Ebola outbreak in Ugandan districts with informative graphical outputs. This favors a rapid global response to the disease, enabling governments to prioritize and adjust their decisions quickly and effectively in response to the rapidly evolving emergency, with a solid data basis.

5 July 2012 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
Tommaso CaiTommaso Cai
Tommaso Cai
Gabriella NesiGabriella Nesi
Gabriella Nesi
SMSandra Mazzoli
Sandra Mazzoli
FMFrancesca Meacci
Francesca Meacci
GTGalliano Tinacci
Galliano Tinacci
RBRiccardo Bartoletti
Riccardo Bartoletti
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

8 July 2012 in Journal of Andrology
Verified
Journal Article
Closed access
PDF file
Tommaso CaiTommaso Cai
Tommaso Cai
FWFlorian Wagenlehner
Florian Wagenlehner
SMSandra Mazzoli
Sandra Mazzoli
FMFrancesca Meacci
Francesca Meacci
NMNicola Mondaini
Nicola Mondaini
RBRiccardo Bartoletti
Riccardo Bartoletti

30 June 2022 in Diseases
Verified
Journal Article
Open access
PDF file
Francesco BrandaFrancesco Branda
Francesco Branda
Ludovico AbenavoliLudovico Abenavoli
Ludovico Abenavoli
MPMassimo Pierini
Massimo Pierini
SMSandra Mazzoli
Sandra Mazzoli
Despite the stunning speed with which highly effective and safe vaccines have been developed, the emergence of new variants of SARS-CoV-2 causes high rates of (re)infection, a major impact on health care services, and a slowdown to the socio-economic system. For COVID-19, accurate and timely forecasts are therefore essential to provide the opportunity to rapidly identify risk areas affected by the pandemic, reallocate the use of health resources, design countermeasures, and increase public awareness. This paper presents the design and implementation of an approach based on autoregressive models to reliably forecast the spread of COVID-19 in Italian regions. Starting from the database of the Italian Civil Protection Department (DPC), the experimental evaluation was performed on real-world data collected from February 2020 to March 2022, focusing on Calabria, a region of Southern Italy. This evaluation shows that the proposed approach achieves a good predictive power for out-of-sample predictions within one week (R-squared > 0.9 at 1 day, R-squared > 0.7 at 7 days), although it decreases with increasing forecasted days (R-squared > 0.5 at 14 days).

1 April 2011 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
Tommaso CaiTommaso Cai
Tommaso Cai
NMNicola Mondaini
Nicola Mondaini
SMSerena Migno
Serena Migno
FMFrancesca Meacci
Francesca Meacci
VBVieri Boddi
Vieri Boddi
RBRiccardo Bartoletti
Riccardo Bartoletti